Anti-inflammatory nutrition as a pharmacological approach to treat obesity

Journal of Obesity

Volumn 2011, Issue , 2011, Pages

  Sears, Barry ^a   Ricordi, Camillo ^b  

^a The Inflammation Research Foundation   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79955582965     PISSN: 20900708     EISSN: 20900716     Source Type: Journal    
DOI: 10.1155/2011/431985     Document Type: Article

References (142)

1. Vachharajani V., Granger D. N., Adipose tissue: a motor for the inflammation associated with obesity. IUBMB life 2009 61 4 424 430 2-s2.0-67650388375 10.1002/iub.169
2. Olefsky J. M., jolefsky@ucsd.edu IKK ε: a bridge between obesity and inflammation. Cell 2009 138 5 834 836 10.1016/j.cell.2009.08.018
3. Wellen K. E., Hotamisligil G. S., ghotamis@hsph.harvard.edu Obesity-induced inflammatory changes in adipose tissue. Journal of Clinical Investigation 2003 112 12 1785 1788 10.1172/JCI200320514 (Pubitemid 38063699)
4. Flegal K. M., kmf2@cdc.gov Carroll M. D., Ogden C. L., Curtin L. R., Prevalence and trends in obesity among US adults, 1999-2008. Journal of the American Medical Association 2010 303 3 235 241 10.1001/jama.2009.2014
5. Serhan C. N., Brain S. D., Buckley C. D., Gilroy D. W., Haslett C., O'Neill L. A. J., Perretti M., Rossi A. G., Wallace J. L., Resolution of inflammation: state of the art, definitions and terms. FASEB Journal 2007 21 2 325 332 2-s2.0-33846823024 10.1096/fj.06-7227rev (Pubitemid 46213480)
6. Serhan C. N., Resolution phase of inflammation: novel endogenous anti-inflammatory and pro-resolving lipid mediators and pathways. Annual Review of Immunology 2007 25 101 137 (Pubitemid 46697904)
7. Sears B, OmegaRx Zone 2002 New York, NY, USA Regan Books
8. Sears B., The Anti-Inflammation Zone 2005 New York, NY, USA Regan Books
9. Sears B, Toxic Fat 2008 New York, NY, USA Regan Books
10. Hotamisligil G. S., Erbay E., Nutrient sensing and inflammation in metabolic diseases. Nature Reviews Immunology 2008 8 12 923 934 2-s2.0-56749164791 10.1038/nri2449
11. Kopp E., Ghosh S., Inhibition of NF- B by sodium salicylate and aspirin. Science 1994 265 5174 956 959 2-s2.0-0028167846
12. Hölschermann H., Schuster D., Parviz B., Haberbosch W., Tillmanns H., Muth H., Statins prevent NF- B transactivation independently of the IKK-pathway in human endothelial cells. Atherosclerosis 2006 185 2 240 245 2-s2.0-33644550593 10.1016/j.atherosclerosis.2005.06.019
13. Tall A. R., C-reactive protein reassessed. The New England Journal of Medicine 2004 350 14 1450 1452 2-s2.0-1842483357 10.1056/NEJMe048020 (Pubitemid 38420000)
14. Campbell B., Badrick T., Flatman R., Kanowski D., Limited clinical utility of high-sensitivity plasma C-reactive protein assays. Annals of Clinical Biochemistry 2002 39 2 85 88 2-s2.0-0036191680 10.1258/0004563021901757 (Pubitemid 34214362)
15. Campbell B., Flatman R., Badrick T., Kanowski D., Ockene I. S., Matthews C. E., Rifai N., Ridker P. M., Reed G., Stanek E., Problems with high-sensitivity C-reactive protein. Clinical Chemistry 2003 49 1 201 202 2-s2.0-0037230467 10.1373/49.1.201 (Pubitemid 36078580)
16. Jenkins D. J. A., Wolever T. M. S., Taylor R. H., Glycemic index of foods: a physiological basis for carbohydrate exchange. American Journal of Clinical Nutrition 1981 34 3 362 366 (Pubitemid 11159124)
17. Ludwig D. S., The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. Journal of the American Medical Association 2002 287 18 2414 2423 2-s2.0-0037042231 (Pubitemid 34495441)
18. Drewnowski A., Specter S. E., Poverty and obesity: the role of energy density and energy costs. American Journal of Clinical Nutrition 2004 79 1 6 16 2-s2.0-1542370542 (Pubitemid 41132056)
19. Drewnoswsi A., Hanks A. S., Smith T. G., Trade, Food, Diet, and Health 2010 West Sussex, UK Wiley-Blackwell
20. Darmon N., Darmon M., Maillot M., Drewnowski A., A nutrient density standard for vegetables and fruits: nutrients per calorie and nutrients per unit cost. Journal of the American Dietetic Association 2005 105 12 1881 1887 2-s2.0-28444475833 10.1016/j.jada.2005.09.005 (Pubitemid 41735324)
21. Drewnowski A., Darmon N., Briend A., Replacing fats and sweets with vegetables and fruits-a question of cost. American Journal of Public Health 2004 94 9 1555 1559 2-s2.0-0344543291 (Pubitemid 39121594)
22. Monsivais P., Drewnowski A., The rising cost of low-energy-density foods. Journal of the American Dietetic Association 2007 107 12 2071 2076 2-s2.0-36448931649 10.1016/j.jada.2007.09.009 (Pubitemid 350166193)
23. Hu F. B., Stampfer M. J., Manson J. E., Rimm E., Colditz G. A., Rosner B. A., Hennekens C. H., Willett W. C., Dietary fat intake and the risk of coronary heart disease in women. The New England Journal of Medicine 1997 337 21 1491 1499 2-s2.0-0030692782 10.1056/NEJM199711203372102 (Pubitemid 27495774)
24. Willett W. C., The role of dietary n-6 fatty acids in the prevention of cardiovascular disease. Journal of Cardiovascular Medicine 2007 8 supplement 1 S42 S45 2-s2.0-34548803928 10.2459/01.JCM.0000289275.72556.13 (Pubitemid 47429082)
25. de Lorgeril M., Renaud S., Mamelle N., Salen P., Martin J.-L., Monjaud I., Guidollet J., Touboul P., Delaye J., Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. The Lancet 1994 343 8911 1454 1459 2-s2.0-0028235692 10.1016/S0140-6736(94)92580-1 (Pubitemid 24176333)
26. de Lorgeril M., Salen P., Martin J.-L., Monjaud I., Delaye J., Mamelle N., Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999 99 6 779 785 2-s2.0-0032955055 (Pubitemid 29083018)
27. Brenner R. R., Nutritional and hormonal factors influencing desaturation of essential fatty acids. Progress in Lipid Research 1982 20 1 41 48 2-s2.0-0019752405
28. El Boustani S., Causse J. E., Descomps B., Monnier L., Mendy F., Crastes de Paulet A., Direct in vivo characterization of delta 5 desaturase activity in humans by deuterium labeling: effect of insulin. Metabolism 1989 38 4 315 321 2-s2.0-0024505850 (Pubitemid 19105715)
29. Pelikanova T., Kohout M., Base J., Stefka Z., Kovar J., Kazdova L., Valek J., Effect of acute hyperinsulinemia on fatty acid composition of serum lipids in non-insulin-dependent diabetics and healthy men. Clinica Chimica Acta 1991 203 2-3 329 337 2-s2.0-0026335142
30. Brenner R. R., Hormonal modulation of δ -6 and δ -5 desaturases: case of diabetes. Prostaglandins Leukotrienes and Essential Fatty Acids 2003 68 2 151 162 2-s2.0-0037323155 10.1016/S0952-3278(02)00265-X (Pubitemid 36216479)
31. Serhan C. N., Arita M., Hong S., Gotlinger K., Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids 2004 39 11 1125 1132 2-s2.0-12344253802 10.1007/s11745-004-1339-7 (Pubitemid 40129055)
32. N. Serhan C., Novel ω -3-derived local mediators in anti-inflammation and resolution. Pharmacology and Therapeutics 2005 105 1 7 21 2-s2.0-11044221394 10.1016/j.pharmthera.2004.09.002 (Pubitemid 40044765)
33. Seki H., Tani Y., Arita M., Omega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1. Prostaglandins and Other Lipid Mediators 2009 89 3-4 126 130 2-s2.0-69549086392 10.1016/j.prostaglandins.2009.03.002
34. Hasturk H., Kantarci A., Goguet-Surmenian E., Blackwood A., Andry C., Serhan C. N., Van Dyke T. E., Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. Journal of Immunology 2007 179 10 7021 7029 2-s2.0-38449114689
35. Simopoulos A. P., Essential fatty acids in health and chronic disease. American Journal of Clinical Nutrition 1999 70 3, supplement 560S 569S 2-s2.0-0032819001 (Pubitemid 29407138)
36. Karelis A. D., Faraj M., Bastard J.-P., St-Pierre D. H., Brochu M., Prud'homme D., Rabasa-Lhoret R., The metabolically healthy but obese individual presents a favorable inflammation profile. Journal of Clinical Endocrinology and Metabolism 2005 90 7 4145 4150 2-s2.0-23044454515 10.1210/jc.2005-0482 (Pubitemid 41058189)
37. Wildman R. P., Muntner P., Reynolds K., McGinn A. P., Rajpathak S., Wylie-Rosett J., Sowers M. R., The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Archives of Internal Medicine 2008 168 15 1617 1624 2-s2.0-49449106657 10.1001/archinte.168.15.1617
38. Unger R. H., Lipotoxic diseases. Annual Review of Medicine 2002 53 319 336 2-s2.0-0036182137 10.1146/annurev.med.53.082901.104057 (Pubitemid 34177884)
39. Unger R. H., Weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 2003 144 12 5159 5165 2-s2.0-0345374579 10.1210/en.2003-0870 (Pubitemid 37476041)
40. Unger R. H., roger.unger@utsouthwestern.edu Clark G. O., Scherer P. E., Orci L., Lipid homeostasis, lipotoxicity and the metabolic syndrome. Biochimica et Biophysica Acta 2010 1801 3 209 214 10.1016/j.bbalip.2009.10.006
41. Virtue S., Sv234@medschl.cam.ac.uk Vidal-Puig A., ajv22@medschl.cam.ac.uk Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome-an allostatic perspective. Biochimica et Biophysica Acta 2010 1801 3 338 349 10.1016/j.bbalip.2009.12.006
42. Massiera F., Saint-Marc P., Seydoux J., Murata T., Kobayashi T., Narumiya S., Guesnet P., Amri E. -Z., Negrel R., Ailhaud G., ailhaud@unice.fr Arachidonic acid and prostacyclin signaling promote adipose tissue development: a human health concern? Journal of Lipid Research 2003 44 2 271 279 10.1194/jlr.M200346-JLR200 (Pubitemid 37287770)
43. Mazid M. A., Chowdhury A. A., Nagao K., Nishimura K., Jisaka M., Nagaya T., Yokota K., Endogenous 15-deoxy-Δ12,14-prostaglandin J2 synthesized by adipocytes during maturation phase contributes to upregulation of fat storage. FEBS Letters 2006 580 30 6885 6890 2-s2.0-33845440071 10.1016/j.febslet.2006.11. 049 (Pubitemid 44909128)
44. Savva S. C., Chadjigeorgiou C., Hatzis C., Kyriakakis M., Tsimbinos G., Tornaritis M., Kafatos A., Association of adipose tissue arachidonic acid content with BMI and overweight status in children from Cyprus and Crete. British Journal of Nutrition 2004 91 4 643 649 2-s2.0-2342526656 10.1079/BJN20031084 (Pubitemid 38584789)
45. Talukdar I., Szeszel-Fedorowicz W., Salati L. M., Arachidonic acid inhibits the insulin induction of glucose-6-phosphate dehydrogenase via p38 MAP kinase. Journal of Biological Chemistry 2005 280 49 40660 40667 2-s2.0-28844478772 10.1074/jbc.M505531200 (Pubitemid 41780557)
46. Sears D. D., Miles P. D., Chapman J., Ofrecio J. M., Almazan F., Thapar D., Miller Y. I., 12/15-lipoxygenase is equired for the early onset of high fat diet-induced adipose tissue inflammation and insulin resistance in mice. PLoS ONE 2009 4 9 2-s2.0-70349639659 10.1371/journal.pone.0007250 e7250
47. Chakrabarti S. K., Cole B. K., Wen Y., Keller S. R., Nadler J. L., 12/15-lipoxygenase products induce inflammation and impair insulin signaling in 3T3-L1 adipocytes. Obesity 2009 17 9 1657 1663 2-s2.0-69749102190 10.1038/oby.2009.192
48. Botion L. M., Green A., Long-term regulation of lipolysis and hormone-sensitive lipase by insulin and glucose. Diabetes 1999 48 9 1691 1697 2-s2.0-0032855712 10.2337/diabetes.48.9.1691 (Pubitemid 29415185)
49. Haemmerle G., Zimmermann R., Zechner R., Letting lipids go: hormone-sensitive lipase. Current Opinion in Lipidology 2003 14 3 289 297 2-s2.0-0038509024 10.1097/00041433-200306000-00009 (Pubitemid 36688208)
50. Williams E. S., Baylin A., Campos H., Adipose tissue arachidonic acid and the metabolic syndrome in Costa Rican adults. Clinical Nutrition 2007 26 4 474 482 2-s2.0-34447649721 10.1016/j.clnu.2007.03.004 (Pubitemid 47091481)
51. Aldamiz-Echevarria L., Prieto J. A., Andrade F., Elorz J., Sanjurjo P., Soriano J. R., Arachidonic acid content in adipose tissue is associated with insulin resistance in healthy children. Journal of Pediatric Gastroenterology and Nutrition 2007 44 1 77 83 2-s2.0-33846038766 10.1097/01.mpg.0000237931. 53470.ba (Pubitemid 46071797)
52. McLaughlin T., Sherman A., Tsao P., Gonzalez O., Yee G., Lamendola C., Reaven G. M., Cushman S. W., Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis. Diabetologia 2007 50 8 1707 1715 2-s2.0-34447130417 10.1007/s00125-007-0708-y (Pubitemid 47036653)
53. Pompeia C., Lima T., Curi R., Arachidonic acid cytotoxicity: can arachidonic acid be a physiological mediator of cell death? Cell Biochemistry and Function 2003 21 2 97 104 2-s2.0-0038249029 10.1002/cbf.1012 (Pubitemid 36597175)
54. Weisberg S. P., McCann D., Desai M., Rosenbaum M., Leibel R. L., Ferrante A. W. Jr., Obesity is associated with macrophage accumulation in adipose tissue. Journal of Clinical Investigation 2003 112 12 1796 1808 2-s2.0-0348230958 10.1172/JCI200319246 (Pubitemid 38063703)
55. Xu H., Barnes G. T., Yang Q., Tan G., Yang D., Chou C. J., Sole J., Nichols A., Ross J. S., Tartaglia L. A., Chen H., Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. Journal of Clinical Investigation 2003 112 12 1821 1830 2-s2.0-9144223683 10.1172/JCI200319451 (Pubitemid 38063705)
56. Ortega Martinez de Victoria E., Xu X., Koska J., Francisco A. M., Scalise M., Ferrante A. W. Jr., Krakoff J., Macrophage content in subcutaneous adipose tissue: associations with adiposity, age, inflammatory markers, and whole-body insulin action in healthy pima Indians. Diabetes 2009 58 2 385 393 2-s2.0-63249106129 10.2337/db08-0536
57. Festa A., D'Agostino R. Jr., Howard G., Mykkänen L., Tracy R. P., Haffner S. M., Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS). Circulation 2000 102 1 42 47 2-s2.0-0034604248 (Pubitemid 30430551)
58. Ruan H., Lodish H. F., Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor- α Cytokine and Growth Factor Reviews 2003 14 5 447 455 2-s2.0-0041374029 10.1016/S1359-6101(03)00052-2 (Pubitemid 37099456)
59. Permana P. A., Menge C., Reaven P. D., Macrophage-secreted factors induce adipocyte inflammation and insulin resistance. Biochemical and Biophysical Research Communications 2006 341 2 507 514 2-s2.0-31444452629 10.1016/j.bbrc.2006.01.012 (Pubitemid 43152134)
60. Shoelson S. E., Lee J., Goldfine A. B., Inflammation and insulin resistance. Journal of Clinical Investigation 2006 116 7 1793 1801 2-s2.0-33745861300 10.1172/JCI29069
61. Neels J. G., Olefsky J. M., Inflamed fat: what starts the fire? Journal of Clinical Investigation 2006 116 1 33 35 2-s2.0-31044447347 10.1172/JCI27280 (Pubitemid 43121788)
62. Cinti S., Mitchell G., Barbatelli G., Murano I., Ceresi E., Faloia E., Wang S., Fortier M., Greenberg A. S., Obin M. S., Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. Journal of Lipid Research 2005 46 11 2347 2355 2-s2.0-27444437321 10.1194/jlr.M500294-JLR200 (Pubitemid 41532523)
63. Lee Y.-H., Pratley R. E., The evolving role of inflammation in obesity and the metabolic syndrome. Current Diabetes Reports 2005 5 1 70 75 2-s2.0-14044257221 (Pubitemid 40277804)
64. Yudkin J. S., Inflammation, obesity, and the metabolic syndrome. Hormone and Metabolic Research 2007 39 10 707 709 2-s2.0-36049023544 10.1055/s-2007-985898 (Pubitemid 350099816)
65. Heilbronn L. K., Campbell L. V., Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. Current Pharmaceutical Design 2008 14 12 1225 1230 2-s2.0-47149096915 10.2174/138161208784246153 (Pubitemid 351997835)
66. de Luca C., Olefsky J. M., Inflammation and insulin resistance. FEBS Letters 2008 582 1 97 105 2-s2.0-37549022688 10.1016/j.febslet.2007.11.057 (Pubitemid 50010731)
67. Kintscher U., Hartge M., Hess K., Foryst-Ludwig A., Clemenz M., Wabitsch M., Fischer-Posovszky P., Barth T. F. E., Dragun D., Skurk T., Hauner H., Blüher M., Unger T., Wolf A. -M., Knippschild U., Hombach V., Marx N., nikolaus.marx@uniklinik-ulm.de T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 7 1304 1310 10.1161/ATVBAHA.108.165100
68. Kahn S. E., Hull R. L., Utzschneider K. M., Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2007 444 7121 840 846 2-s2.0-33845881411 10.1038/nature05482
69. Chavez J. A., Summers S. A., Lipid oversupply, selective insulin resistance, and lipotoxicity: molecular mechanisms. Biochimica et Biophysica Acta 2010 1801 3 252 265 2-s2.0-70350139101 10.1016/j.bbalip.2009.09.015
70. Todoric J., Löffler M., Huber J., Bilban M., Reimers M., Kadl A., Zeyda M., Waldhäusl W., Stulnig T. M., Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n-3 polyunsaturated fatty acids. Diabetologia 2006 49 9 2109 2119 2-s2.0-33746772121 10.1007/s00125-006-0300-x (Pubitemid 44168479)
71. Huber J., Löffler M., Bilban M., Reimers M., Kadl A., Todoric J., Zeyda M., Geyeregger R., Schreiner M., Weichhart T., Leitinger N., Waldhäusl W., Stulnig T. M., Prevention of high-fat diet-induced adipose tissue remodeling in obese diabetic mice by n-3 polyunsaturated fatty acids. International Journal of Obesity 2007 31 6 1004 1013 2-s2.0-34249812073 10.1038/sj.ijo.0803511 (Pubitemid 46844776)
72. Perez-Martinez P., Perez-Jimenez F., Lopez-Miranda J., n-3 PUFA and lipotoxicity. Biochimica et Biophysica Acta 2010 1801 3 362 366 2-s2.0-70349891886 10.1016/j.bbalip.2009.09.010
73. Nguyen X.-M. T., Lane J., Smith B. R., Nguyen N. T., Changes in inflammatory biomarkers across weight classes in a representative US population: a link between obesity and inflammation. Journal of Gastrointestinal Surgery 2009 13 7 1205 1212 2-s2.0-67349226375 10.1007/s11605-009-0904-9
74. Aguilar-Salinas C. A., García E., Robles L., Riaño D., Ruiz-Gomez D. G., García-Ulloa A. C., Melgarejo M. A., Zamora M., Guillen-Pineda L. E., Mehta R., Canizales-Quinteros S., Luna M. T. T., Gómez-Pérez F. J., High adiponectin concentrations are associated with the metabolically healthy obese phenotype. Journal of Clinical Endocrinology and Metabolism 2008 93 10 4075 4079 2-s2.0-53249149870 10.1210/jc.2007-2724
75. Kim J.-Y., Van De Wall E., Laplante M., Azzara A., Trujillo M. E., Hofmann S. M., Schraw T., Durand J. L., Li H., Li G., Jelicks L. A., Mehler M. F., Hui D. Y., Deshaies Y., Shulman G. I., Schwartz G. J., Scherer P. E., Obesity-associated improvements in metabolic profile through expansion of adipose tissue. Journal of Clinical Investigation 2007 117 9 2621 2637 2-s2.0-34848872799 10.1172/JCI31021 (Pubitemid 47494363)
76. Neschen S., Morino K., Rossbacher J. C., Pongratz R. L., Cline G. W., Sono S., Gillum M., Shulman G. I., Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptor- γ -dependent mechanism in mice. Diabetes 2006 55 4 924 928 2-s2.0-33745305434 10.2337/diabetes.55.04.06. db05-0985 (Pubitemid 44100165)
77. Banga A., Unal R., Tripathi P., Pokrovskaya I., Owens R. J., Kern P. A., Ranganathan G., Adiponectin translation is increased by the PPAR γ agonists pioglitazone and ω -3 fatty acids. American Journal of Physiology 2009 296 3 E480 E489 2-s2.0-64749086879 10.1152/ajpendo.90892.2008
78. Itoh M., Suganami T., Satoh N., Tanimoto-Koyama K., Yuan X., Tanaka M., Kawano H., Yano T., Aoe S., Takeya M., Shimatsu A., Kuzuya H., Kamei Y., Ogawa Y., Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 9 1918 1925 2-s2.0-34548274430 10.1161/ATVBAHA.106.136853 (Pubitemid 47315642)
79. Unger R. H., runger@mednet.swmed.edu. Zhou Y.-T., Lipotoxicity of β -cells in obesity and in other causes of fatty acid spillover. Diabetes 2001 50 supplement 1 S118 S121 (Pubitemid 32148232)
80. Baylin A., Campos H., Arachidonic acid in adipose tissue is associated with nonfatal acute myocardial infarction in the Central Valley of Costa Rica. Journal of Nutrition 2004 134 11 3095 3099 2-s2.0-7944236166 (Pubitemid 39470090)
81. Ridker P. M., Danielson E., Fonseca F. A. H., Genest J., Gotto A. M. Jr., Kastelein J. J. P., Koenig W., Libby P., Lorenzatti A. J., MacFadyen J. G., Nordestgaard B. G., Shepherd J., Willerson J. T., Glynn R. J., Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. The New England Journal of Medicine 2008 359 21 2195 2207 2-s2.0-56749106312 10.1056/NEJMoa0807646
82. Fruchart J.-C., Duriez P., Mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism. Drugs of Today 2006 42 1 39 64 2-s2.0-33645076793 10.1358/dot.2006.42.1.963528
83. Savage D. B., PPAR γ as a metabolic regulator: insights from genomics and pharmacology. Expert Reviews in Molecular Medicine 2005 7 1 1 16 2-s2.0-13944274395 10.1017/S1462399405008793 (Pubitemid 43118238)
84. Studer M., Briel M., Leimenstoll B., Glass T. R., Bucher H. C., Effect of different antilipidemic agents and diets on mortality: a systematic review. Archives of Internal Medicine 2005 165 7 725 730 2-s2.0-17644421390 10.1001/archinte.165.7.725 (Pubitemid 40569423)
85. Nissen S. E., Wolski K., Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. The New England Journal of Medicine 2007 356 24 2457 2471 2-s2.0-34250212715 (Pubitemid 46919772)
86. Hattori Y., Suzuki K., Hattori S., Kasai K., Metformin inhibits cytokine-induced nuclear factor B activation via AMP-activated protein kinase activation in vascular endothelial cells. Hypertension 2006 47 6 1183 1188 2-s2.0-33744976813 10.1161/01.HYP.0000221429.94591.72 (Pubitemid 44289177)
87. Fryer L. G. D., Parbu-Patel A., Carling D., The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. Journal of Biological Chemistry 2002 277 28 25226 25232 2-s2.0-0037067666 10.1074/jbc.M202489200 (Pubitemid 34951829)
88. Wong A. K. F., Howie J., Petrie J. R., Lang C. C., AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease. Clinical Science 2009 116 8 607 620 2-s2.0-66949121471 10.1042/CS20080066
89. Golay A., Metformin and body weight. International Journal of Obesity 2008 32 1 61 72 2-s2.0-38149077951 10.1038/sj.ijo.0803695
90. Christensen R., Kristensen P. K., Bartels E. M., Bliddal H., Astrup A., Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. The Lancet 2007 370 9600 1706 1713 2-s2.0-36048995288 10.1016/S0140-6736(07)61721-8 (Pubitemid 350100788)
91. Beckman L. M., Beckman T. R., Earthman C. P., Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass procedure: a review. Journal of the American Dietetic Association 2010 110 4 571 584 10.1016/j.jada.2009.12. 023
92. Rasmusen N., On Speed: The Many Lives of Amphetamine 2009 New York, NY, USA NYU Press
93. Connolly H. M., Crary J. L., McGoon M. D., Hensrud D. D., Edwards B. S., Edwards W. D., Schaff H. V., Valvular heart disease associated with fenfluramine phentermine. The New England Journal of Medicine 1997 337 9 581 588 2-s2.0-0030876952 10.1056/NEJM199708283370901 (Pubitemid 27360757)
94. Sears B., The Zone 1995 New York, NY, USA Regan Books
95. Sears B., bsears@drsears.com Anti-inflammatory diets for obesity and diabetes. Journal of the American College of Nutrition 2009 28 1, supplement 1 482S 491S
96. Ramakers J. D., Mensink R. P., Schaart G., Plat J., Arachidonic acid but not eicosapentaenoic acid (EPA) and oleic acid activates NF- B and elevates ICAM-1 expression in Caco-2 cells. Lipids 2007 42 8 687 698 2-s2.0-34548213672 10.1007/s11745-007-3071-3 (Pubitemid 47328753)
97. Lee J. Y., Ye J., Gao Z., Youn H. S., Lee W. H., Zhao L., Sizemore N., Hwang D. H., Reciprocal modulation of toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. Journal of Biological Chemistry 2003 278 39 37041 37051 2-s2.0-0141844653 10.1074/jbc.M305213200 (Pubitemid 37175218)
98. Lee J. Y., Zhao L., Youn H. S., Weatherill A. R., Tapping R., Feng L., Lee W. H., Fitzgerald K. A., Hwang D. H., Saturated fatty acid activates but polyunsaturated fatty acid inhibits toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. Journal of Biological Chemistry 2004 279 17 16971 16979 2-s2.0-2342435824 10.1074/jbc.M312990200 (Pubitemid 38560450)
99. Suganami T., Tanimoto-Koyama K., Nishida J., Itoh M., Yuan X., Mizuarai S., Kotani H., Yamaoka S., Miyake K., Aoe S., Kamei Y., Ogawa Y., Role of the Toll-like receptor 4/NF- B pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 1 84 91 2-s2.0-33846323706 10.1161/01.ATV.0000251608.09329.9a (Pubitemid 46370478)
100. Kennedy A., Martinez K., Chuang C.-C., Lapoint K., Mcintosh M., Saturated fatty acid-mediated inflammation and insulin resistance in adipose tissue: mechanisms of action and implications. Journal of Nutrition 2009 139 1 1 4 2-s2.0-58649096801 10.3945/jn.108.098269
101. Shi H., Kokoeva M. V., Inouye K., Tzameli I., Yin H., Flier J. S., TLR4 links innate immunity and fatty acid-induced insulin resistance. Journal of Clinical Investigation 2006 116 11 3015 3025 2-s2.0-33750584214 10.1172/JCI28898 (Pubitemid 44684486)
102. Kim F., Pham M., Luttrell I., Bannerman D. D., Tupper J., Thaler J., Hawn T. R., Raines E. W., Schwartz M. W., Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circulation Research 2007 100 11 1589 1596 2-s2.0-34250169823 10.1161/CIRCRESAHA.106.142851 (Pubitemid 46897262)
103. Zhang X., Zhang G., Zhang H., Karin M., Bai H., Cai D., Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell 2008 135 1 61 73 2-s2.0-52949096557 10.1016/j.cell.2008.07.043
104. Denys A., Hichami A., Khan N. A., n-3 PUFAs modulate T-cell activation via protein kinase C- α and-ε and the NF- B signaling pathway. Journal of Lipid Research 2005 46 4 752 758 2-s2.0-21744448372 10.1194/jlr.M400444-JLR200 (Pubitemid 43073285)
105. Romier B., Van De Walle J., During A., Larondelle Y., Schneider Y. -J., yjs@uclouvain.be Modulation of signalling nuclear factor- B activation pathway by polyphenols in human intestinal Caco-2 cells. British Journal of Nutrition 2008 100 3 542 551 10.1017/S0007114508966666
106. Lee J. Y., Plakidas A., Lee W. H., Heikkinen A., Chanmugam P., Bray G., Hwang D. H., Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. Journal of Lipid Research 2003 44 3 479 486 2-s2.0-0038143617 10.1194/jlr.M200361-JLR200 (Pubitemid 37279695)
107. von Schacky C., A review of omega-3 ethyl esters for cardiovascular prevention and treatment of increased blood triglyceride levels. Vascular Health and Risk Management 2006 2 3 251 262 2-s2.0-33747776158 10.2147/vhrm.2006.2.3. 251 (Pubitemid 44275461)
108. Li H., Ruan X. Z., Powis S. H., Fernando R., Mon W. Y., Wheeler D. C., Moorhead J. F., Varghese Z., EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR- γ -dependent mechanism. Kidney International 2005 67 3 867 874 2-s2.0-20844440063 10.1111/j.1523-1755. 2005.00151.x (Pubitemid 41623311)
109. Pliquett R. U., Führer D., Falk S., Zysset S., Von Cramon D. Y., Stumvoll M., The effects of insulin on the central nervous system-focus on appetite regulation. Hormone and Metabolic Research 2006 38 7 442 446 2-s2.0-33748080457 10.1055/s-2006-947840 (Pubitemid 44298771)
110. Davidowa H., Plagemann A., Insulin resistance of hypothalamic arcuate neurons in neonatally overfed rats. NeuroReport 2007 18 5 521 524 2-s2.0-34247552309 10.1097/WNR.0b013e32805dfb93 (Pubitemid 46668046)
111. Schwartz M. W., Porte D. Jr., Diabetes, obesity, and the brain. Science 2005 307 5708 375 379 2-s2.0-12344277552 10.1126/science.1104344 (Pubitemid 40139972)
112. Scarpace P. J., Zhang Y., Leptin resistance: a prediposing factor for diet-induced obesity. American Journal of Physiology 2009 296 3 R493 R500 2-s2.0-64149130937 10.1152/ajpregu.90669.2008
113. Martin S. S., Qasim A., Reilly M. P., Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. Journal of the American College of Cardiology 2008 52 15 1201 1210 2-s2.0-52949129178 10.1016/j.jacc.2008.05.060
114. Rapoport S. I., Arachidonic acid and the brain. Journal of Nutrition 2008 138 12 2515 2520 2-s2.0-57349111168
115. Watanabe S., Doshi M., Hamazaki T., n-3 polyunsaturated fatty acid (PUFA) deficiency elevates and n-3 PUFA enrichment reduces brain 2- arachidonoylglycerol level in mice. Prostaglandins Leukotrienes and Essential Fatty Acids 2003 69 1 51 59 2-s2.0-0242492997 10.1016/S0952-3278(03)00056-5 (Pubitemid 37421501)
116. Chen C. T., Liu Z., Ouellet M., Calon F., Bazinet R. P., Rapid β -oxidation of eicosapentaenoic acid in mouse brain: an in situ study. Prostaglandins Leukotrienes and Essential Fatty Acids 2009 80 2-3 157 163 2-s2.0-62149092899 10.1016/j.plefa.2009.01.005
117. Batterham R. L., Heffron H., Kapoor S., Chivers J. E., Chandarana K., Herzog H., Le Roux C. W., Thomas E. L., Bell J. D., Withers D. J., Critical role for peptide YY in protein-mediated satiation and body-weight regulation. Cell Metabolism 2006 4 3 223 233 2-s2.0-33748128913 10.1016/j.cmet.2006.08.001 (Pubitemid 44307976)
118. Chalon S., Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins Leukotrienes and Essential Fatty Acids 2006 75 4-5 259 269 2-s2.0-33748972432 10.1016/j.plefa.2006.07.005 (Pubitemid 44442912)
119. Sorgi P. J., Hallowell E. M., Hutchins H. L., Sears B., Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder. Nutrition Journal 2007 6, article 16 2-s2.0-34548724398 10.1186/1475-2891-6-16 (Pubitemid 350092646)
120. Germano M., Meleleo D., Montorfano G., Adorni L., Negroni M., Berra B., Rizzo A. M., Plasma, red blood cells phospholipids and clinical evaluation after long chain omega-3 supplementation in children with attention defict hyperactivity disorder (ADHD). Nutritional Neuroscience 2007 10 1-2 1 9 10.1080/10284150601153801 (Pubitemid 46671777)
121. Hwang J.-T., Kwon D. Y., Yoon S. H., AMP-activated protein kinase: a potential target for the diseases prevention by natural occurring polyphenols. New Biotechnology 2009 26 1-2 17 22 2-s2.0-65849459099 10.1016/j.nbt.2009.03.005
122. Zang M., Xu S., Maitland-Toolan K. A., Zuccollo A., Hou X., Jiang B., Wierzbicki M., Verbeuren T. J., Cohen R. A., Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 2006 55 8 2180 2191 2-s2.0-33749349202 10.2337/db05-1188 (Pubitemid 44743614)
123. Takikawa M., Inoue S., Horio F., Tsuda T., tsudat@isc.chubu.ac.jp Dietary anthocyanin-rich bilberry extract ameliorates hyperglycemia and insulin sensitivity via activation of amp-activated protein kinase in diabetic mice. Journal of Nutrition 2010 140 3 527 533 10.3945/jn.109.118216
124. Johnston C. S., Day C. S., Swan P. D., Postprandial thermogenesis is increased 100% on a high-protein, low-fat diet versus a high-carbohydrate, low-fat diet in healthy, young women. Journal of the American College of Nutrition 2002 21 1 55 61 2-s2.0-0036163681 (Pubitemid 34123710)
125. Layman D. K., Baum J. I., Dietary protein impact on glycemic control during weight loss. Journal of Nutrition 2004 134 4 968S 973S 2-s2.0-1842530346 (Pubitemid 38456273)
126. Norton L. E., Layman D. K., Bunpo P., Anthony T. G., Brana D. V., Garlick P. J., The leucine content of a complete meal directs peak activation but not duration of skeletal muscle protein synthesis and mammalian target of rapamycin signaling in rats. Journal of Nutrition 2009 139 6 1103 1109 2-s2.0-66749157399 10.3945/jn.108.103853
127. Layman D. K., dlayman@illinois.edu Dietary guidelines should reflect new understandings about adult protein needs. Nutrition and Metabolism 2009 6, article 12 10.1186/1743-7075-6-12
128. Institute of Medicine of the National Academies, Dietary Reference Intake for Energy, Carbohydrates, Fat, Fiber, Fatty Acids, Cholesterol, Protein, and Amino Acids 2002 Washington, DC, USA National Academies Press
129. Sacks F. M., Bray G. A., Carey V. J., Smith S. R., Ryan D. H., Anton S. D., McManus K., Champagne C. M., Bishop L. M., Laranjo N., Leboff M. S., Rood J. C., De Jonge L., Greenway F. L., Loria C. M., Obarzanek E., Williamson D. A., Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. The New England Journal of Medicine 2009 360 9 859 873 2-s2.0-61449183682 10.1056/NEJMoa0804748
130. Gardner C. D., Kiazand A., Alhassan S., Kim S., Stafford R. S., Balise R. R., Kraemer H. C., King A. C., Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A to Z weight loss study: a randomized trial. Journal of the American Medical Association 2007 297 9 969 977 2-s2.0-33847723397 10.1001/jama.297.9.969 (Pubitemid 46376751)
131. Dansinger M. L., Gleason J. A., Griffith J. L., Selker H. P., Schaefer E. J., Comparison of the Atkins, Ornish, Weight Watchers, and Zone Diets for weight loss and heart disease risk reduction: a randomized trial. Journal of the American Medical Association 2005 293 1 43 53 2-s2.0-11244331742 10.1001/jama.293.1.43 (Pubitemid 40066698)
132. Layman D. K., The role of leucine in weight loss diets and glucose homeostasis. Journal of Nutrition 2003 133 1 261S 267S 2-s2.0-0037224768 (Pubitemid 36070614)
133. Raatz S. K., Torkelson C. J., Redmon J. B., Reck K. P., Kwong C. A., Swanson J. E., Liu C., Thomas W., Bantle J. P., Reduced glycemic index and glycemic load diets do not increase the effects of energy restriction on weight loss and insulin sensitivity in obese men and women. Journal of Nutrition 2005 135 10 2387 2391 2-s2.0-26444455601 (Pubitemid 41429596)
134. Ebbeling C. B., Leidig M. M., Feldman H. A., Lovesky M. M., Ludwig D. S., Effects of a low-glycemic load vs low-fat diet in obese young adults: a randomized trial. Journal of the American Medical Association 2007 297 19 2092 2102 2-s2.0-34248551882 10.1001/jama.297.19.2092 (Pubitemid 46798167)
135. Pittas A. G., Roberts S. B., Das S. K., Gilhooly C. H., Saltzman E., Golden J., Stark P. C., Greenberg A. S., The effects of the dietary glycemic load on type 2 diabetes risk factors during weight loss. Obesity 2006 14 12 2200 2209 2-s2.0-33846290758 (Pubitemid 46121976)
136. Pittas A. G., Das S. K., Hajduk C. L., Golden J., Saltzman E., Stark P. C., Greenberg A. S., Roberts S. B., A low-glycemic load diet facilitates greater weight loss in overweight adults with high insulin secretion but not in overweight adults with low insulin secretion in the CALERIE trial. Diabetes Care 2005 28 12 2939 2941 2-s2.0-33644827142 10.2337/diacare.28.12.2939 (Pubitemid 43942928)
137. Pereira M. A., Swain J., Goldfine A. B., Rifai N., Ludwig D. S., Effects of a low-glycemic load diet on resting energy expenditure and heart disease risk factors during weight loss. Journal of the American Medical Association 2004 292 20 2482 2490 2-s2.0-9244264413 10.1001/jama.292.20.2482 (Pubitemid 39552673)
138. Joslin Diabetes Research Center Dietary Guidelines,. http://www.joslin. org/docs/nutrition-guideline-graded.pdf
139. Hamdy O., Carver C., The why WAIT program: improving clinical outcomes through weight management in type 2 diabetes. Current Diabetes Reports 2008 8 5 413 420 2-s2.0-58149384417 10.1007/s11892-008-0071-5
140. Sears B., Mastering the Zone 1997 New York, NY, USA Regan Books
141. Wing R. R., Phelan S., Long-term weight loss maintenance. The American Journal of Clinical Nutrition 2005 82 1, supplement 222S 225S
142. Wing R. R., Hill J. O., Successful weight loss maintenance. Annual Review of Nutrition 2001 21 323 341 2-s2.0-0034943548 10.1146/annurev.nutr.21.1.323 (Pubitemid 32695275)